Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
about
Evidence that opioids may have toll-like receptor 4 and MD-2 effectsRegulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding siteEndogenous morphine levels are increased in sepsis: a partial implication of neutrophils.Opiates, immune system, acquired immunodeficiency syndrome, and nonhuman primate model.Anticipating and treating opioid-associated adverse effects.Activation of μ opioid receptors modulates inflammation in acute experimental colitis.Does Opioid Use Cause Angiogenesis and Metastasis?A role for reactive oxygen species in endotoxin-induced elevation of MOR expression in the nervous and immune systemsProtective role of μ opioid receptor activation in intestinal inflammation induced by mesenteric ischemia/reperfusion in mice.Nuclear factor kappaB signaling in opioid functions and receptor gene expressionRegulation of mu opioid receptor expression in developing T cells.Morphine induces splenocyte trafficking into the CNS.Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells.Battle of animal models.Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.Opiates and the development of post-injury complications: a review.Role of the mu-opioid receptor in opioid modulation of immune function.Pharmacological Profiles of Oligomerized μ-Opioid Receptors.Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control.Methadone enhances human influenza A virus replication.Transcriptional regulation of mouse mu opioid receptor gene by PU.1.Could Perioperative Opioid Use Increase the Risk of Cancer Progression and Metastases?Ketamine, as adjuvant analgesics for patients with refractory cancer pain, does affect IL-2/IFN-γ expression of T cells in vitro?: A prospective, randomized, double-blind studyInfluence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors.Opioid receptor blockade reduces Fas-induced hepatitis in mice.Endogenous delta-opioid and ORL1 receptors couple to phosphorylation and activation of p38 MAPK in NG108-15 cells and this is regulated by protein kinase A and protein kinase C.Congenic C57BL/6 mu opiate receptor (MOR) knockout mice: baseline and opiate effects.Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain.Remifentanil attenuates human neutrophils activation induced by lipopolysaccharide.Perioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain ManagementElevated methylation of OPRM1 and OPRL1 genes in Alzheimer's disease
P2860
Q28254885-BE0FD9CD-FE99-4C6B-A7F7-38F98A2BBC85Q28574561-0CEA15DC-E77B-4973-8B03-5BC6CAD61602Q33526332-A80A8B9F-0B36-4CB8-B02B-7F9283972C86Q33861574-8DD46B8A-3BD5-4166-9354-4156574EA9DAQ35194392-3DC4605F-E31F-46ED-9728-FEAB6489D2F4Q35510067-8E58548E-29E2-4084-9B94-A14C9B9AEFEAQ36062073-1AAE84EF-0200-41FD-BA36-B0D0B06F8D0AQ36160039-5E27EBD5-1E0E-4E01-AFB2-DEF89B892673Q36227327-E0126595-1000-4B60-AC76-134FA5D212A0Q36245077-2F66A0B7-C9A6-4090-A17C-42837B8925F8Q36457158-AC8E6417-B872-477A-8D16-41BB3E1F4813Q36603264-005139CA-2C18-41E3-BA26-AA40A2065964Q36807974-B243877C-8D3B-4BC2-B300-E99ECBB7E345Q37015533-00F30FAD-B54E-4529-968A-431313E37441Q37241460-BFF05417-9C68-40F0-AFC8-56BF0EE3ECCAQ37349921-2590FA57-53E1-4AA2-A220-5E1853FFDA8AQ37551339-1EF12F00-FFE4-45BC-94BF-BD1D1EAAB8C0Q37679197-2A47EE73-C33E-4F81-868A-892F1605AC6FQ39750331-BA4D83EF-22E8-4888-925B-8C0AF56EECF6Q39887680-7F0BF8BB-CA98-4B98-BAC3-A39D184A84FCQ40561436-FF908416-96AE-4688-9D6B-FCABA2ECDA5FQ40582735-DE4A9941-ADC0-460B-8F0A-CB66A4455BD9Q41644051-5C9AC365-D725-4595-8850-180D6B1117F9Q41910230-6D642107-04DC-4359-8C97-6ACA591D00C2Q44330756-3D938987-928A-464B-9E6C-A58D838636B7Q44346833-AB9FFA0A-638C-430B-9C80-90A3F8533699Q44352849-FCB4EBC2-CA13-4392-A3CA-996953D70ABEQ44528499-A09A9C2C-1E44-4278-B917-48DD4EFF3D2EQ44887369-049605A4-1E96-4342-AD15-3AFB1116F98AQ48028267-1CED956C-EBED-4031-AE39-27C47C0448B4Q57493011-DE74CBBC-7126-40CB-9B44-7D3BFE4DC995Q58703542-EDF25214-C54D-4C33-953D-44B394B96D81
P2860
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@en
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@nl
type
label
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@en
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@nl
prefLabel
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@en
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@nl
P2093
P2860
P356
P1476
Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene.
@en
P2093
B L Kieffer
C Gavériaux-Ruff
H W Matthes
P2860
P304
P356
10.1073/PNAS.95.11.6326
P407
P577
1998-05-01T00:00:00Z